Improving Adherence to Weight-Loss Medication (Liraglutide 3.0 mg) Using Mobile Phone Text Messaging and Healthcare Professional Support
- PMID: 32902905
- PMCID: PMC7589266
- DOI: 10.1002/oby.22930
Improving Adherence to Weight-Loss Medication (Liraglutide 3.0 mg) Using Mobile Phone Text Messaging and Healthcare Professional Support
Abstract
Background: Adherence to weight-loss medication is suboptimal, leading to poor health outcomes. Short message service (SMS) can potentially improve adherence.
Methods: A total of 3,994 participants with overweight or obesity in Australia receiving Saxenda® (liraglutide 3.0 mg) were enrolled from September 1, 2017, to February 28, 2018, through doctors, pharmacists, or websites and were randomly assigned to receive none, three, or five SMS per week. Participants were additionally offered a face-to-face consultation with a diabetes educator or a call from a dietitian. Medication adherence was measured as whether the total scripts claimed were at least as many as the total claims expected by March 31, 2018, and was modeled adjusting for age, sex, baseline BMI, residential region, enrolment channel, the total number of SMS, and additional patient support.
Results: Participants receiving five SMS (OR, 6.25; 95% CI: 4.28-9.12) had greater adherence than those receiving three SMS (OR, 3.67; 95% CI: 2.67-5.03) or zero SMS per week. The effectiveness of SMS on adherence decreased as participants received more SMS over time. Moreover, the odds of adhering to liraglutide were higher for participants enrolled with pharmacists compared with those enrolled with doctors (OR, 2.28; 95% CI: 1.82-2.86) and for participants who received a face-to-face consultation (OR, 3.10; 95% CI: 1.82-5.29) or a call (OR, 1.31; 95% CI: 1.02-1.68) compared with those who received no extra support.
Conclusions: Integration of SMS into routine clinical practice should consider not only the frequency and content of reminders but also additional patient support to achieve higher and more sustained adherence to medication and health behavior changes.
© 2020 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS).
Conflict of interest statement
NF and IC have received research grants for clinical trials funded by Bristol‐Myers Squibb, Rhythm Pharmaceuticals, Novo Nordisk, Australian Eggs Corporation, Zafgen, GlaxoSmithKline, Millendo, and Pfizer. NF is the author of
Figures
Similar articles
-
Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial.Circulation. 2016 Feb 9;133(6):592-600. doi: 10.1161/CIRCULATIONAHA.115.017530. Epub 2016 Jan 14. Circulation. 2016. PMID: 26769742 Free PMC article. Clinical Trial.
-
Mobile phone intervention for increasing adherence to treatment for type 2 diabetes in an urban area of Bangladesh: protocol for a randomized controlled trial.BMC Health Serv Res. 2014 Nov 26;14:586. doi: 10.1186/s12913-014-0586-1. BMC Health Serv Res. 2014. PMID: 25424425 Free PMC article. Clinical Trial.
-
Therapeutic effects of mobile-based text message reminders for medication adherence in bipolar I disorder: Are they maintained after intervention cessation?J Psychiatr Res. 2018 Sep;104:163-168. doi: 10.1016/j.jpsychires.2018.07.013. Epub 2018 Jul 26. J Psychiatr Res. 2018. PMID: 30081390 Clinical Trial.
-
Integrative Review of Mobile Phone Contacts and Medication Adherence in Severe Mental Illness.J Am Psychiatr Nurses Assoc. 2018 May/Jun;24(3):209-222. doi: 10.1177/1078390318754986. Epub 2018 Feb 19. J Am Psychiatr Nurses Assoc. 2018. PMID: 29457508 Review.
-
Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis.JAMA Intern Med. 2016 Mar;176(3):340-9. doi: 10.1001/jamainternmed.2015.7667. JAMA Intern Med. 2016. PMID: 26831740 Review.
Cited by
-
Key Elements and Theoretical Foundations for the Design and Delivery of Text Messages to Boost Medication Adherence in Patients With Diabetes, Hypertension, and Hyperlipidemia: Scoping Review.J Med Internet Res. 2025 Jul 21;27:e71982. doi: 10.2196/71982. J Med Internet Res. 2025. PMID: 40690759 Free PMC article.
-
Effect of a smartphone application (Perx) on medication adherence and clinical outcomes: a 12-month randomised controlled trial.BMJ Open. 2021 Aug 9;11(8):e047041. doi: 10.1136/bmjopen-2020-047041. BMJ Open. 2021. PMID: 34373299 Free PMC article. Clinical Trial.
-
Mindfulness and Mobile Health for Quitting Smoking: A Qualitative Study Among Predominantly African American Adults with Low Socioeconomic Status.Am J Qual Res. 2022;6(1):19-41. doi: 10.29333/ajqr/11427. Am J Qual Res. 2022. PMID: 35392178 Free PMC article.
-
Pharmacological interventions for addressing pediatric and adolescent obesity: A systematic review and network meta-analysis.PLoS One. 2025 Feb 27;20(2):e0314787. doi: 10.1371/journal.pone.0314787. eCollection 2025. PLoS One. 2025. PMID: 40014613 Free PMC article.
-
Impact of text message reminders on immunosuppressive medication adherence among kidney transplant recipients: A randomized controlled study.J Eval Clin Pract. 2025 Feb;31(1):e14178. doi: 10.1111/jep.14178. Epub 2024 Oct 16. J Eval Clin Pract. 2025. PMID: 39415490 Free PMC article. Clinical Trial.
References
-
- World Health Organization . Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Updated April 1, 2020. Geneva: World Health Organization; 2017.
-
- Australian Institute of Health and Welfare . Health Communities: Overweigt ans obesity rates across Australia, 2014‐15. Canberra, Australia: Australian Institute of Health and Welfare, Australian Government; 2016.
-
- Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993;153:1863‐1868. - PubMed
-
- Haynes RB, McDonald HP, Garg A, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002:CD000011. doi:10.1002/14651858.CD000011 - DOI - PubMed
-
- Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health‐related quality of life, and health care costs. Pharmacotherapy 2000;20:941‐949. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous